the story of glp 1 Timeline GLP-1 discovery and clinical development. (a) Key events in The Story of GLP-1 -

Further, since this was an investigation focused a priori on S-5-HT levels, it remains unknown if the effects were specific to serotonin synthesis, or if other pathways were also affected

It could be that my expectations were too high, but either way, it didnt deliver on those

Co-agonism showed, on murine models, the capability to improve insulin secretion and sensitivity in a weight-dependent and weight-independent manner, probably through its action on nutrient metabolism ( 1.5 Other possible pleiotropic effects of Tirzepatide Pleiotropic effects of GIP receptor stimulation in other tissues, mediated by mechanisms other than typical protein G-coupled receptor pathways, might bring additional benefits

IGF-1 LR3 is a full agonist at the type 1 IGF receptor (IGF-1R), a transmembrane receptor tyrosine kinase

doi: 10.1016/j.bioorg.2023.106394 [DOI] [PubMed] [Google Scholar] 215.Li H, Zhang X, Gu L, et al